Glyco-Signals in Regulatory Mechanisms For Proliferation, Differentiation, Senescence And Apoptosis of Hematopoietic Cells.

造血细胞增殖、分化、衰老和凋亡调节机制中的糖信号。

基本信息

  • 批准号:
    08457270
  • 负责人:
  • 金额:
    $ 4.99万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1996
  • 资助国家:
    日本
  • 起止时间:
    1996 至 1997
  • 项目状态:
    已结题

项目摘要

During the period from 1996 to 1997, the following new findings were obtained, and most of them were presented in some of the international conferences, and published in the specialized journals : (1) The interaction of the extracellular matrix glycoprotein, fibronectin, with the integrin VLA-5 was shown to be intimately related with the apoptotic phenomena of hematopoietic cells. (2) A significant enhancement of the expression of VLA-5 mRNA was observed only in the monocytic, but not granulocytic, differentiation of human myelogenous leukemia HL-60 cells. (3) The expression of integrin VLA-5 on the cell surface was enhanced exclusively in the process of monocytic differentiation, and the most prominent expression was observed on the surface of peripheral mature monocytes. (4) The sensitivity of fibronectin-induced apoptosis was remarkably increased during monocytic differentiation, and the anti-VLA-5 monoclonal antibody or the RGD peptide completely abolished it. (5) Apoptosis of the … More normal monocytes, but not granulocytes, from peripheral blood was significantly increased by the extracellular matrix fibronectin, and the anti-fibronectin monoclonal antibody suppressed the apoptosis and increased the survival time of normal monocytes. (6) Expression of the extracellular matrix glycoprotein, tenascin, was restricted spatially and temporally during the formation of tumor tissues, depending upon the stromal-epithelial interactions, and the de novo synthesis of tenascins was induced by the soluble growth factor EGF,being also dependent on the stromal-epithelial interactions. Human tenascin C is shown to have the EGF-like domain, but this domain and its derivative peptide could not induce the expression of tenascin. (7) With all the current data taken together, it is concluded that the ECM glycoprotein fibronectin might play an important role as the negative regulator for the survival of monocytes in collaboration with the integrin VLA-5, which characteristically increases during the process of monocytic differentiation.In the latter part of the present research projects, the following novel findings were demonstrated : (8) Using the elaborately-devised expression cloning method, we have succeeded for the first time in isolating and molecularly characterizing a new and relevant gene (cDNA and its genome) which encodes a key glycosyltransferase, ganglioside GM3 synthase (sialyltransferase-1) , responsible for the biosynthesis of a ubiquitous but intriguing membraneous molecule of the simplest structure, ganglioside GM3. GM3 was previously demonstrated to exhibit a variety of biological functions intimately related to the cell growth control, malignant transformations, the cell-to-cell recognitions, and the differentiation-induction of human myelogenousleukemia cells. Less
1996年至1997年期间,获得了以下新发现,其中大部分在一些国际会议上发表,并发表在专业期刊上:(1)细胞外基质糖蛋白纤连蛋白与细胞外基质糖蛋白的相互作用整合素VLA-5被证明与造血细胞的凋亡现象密切相关(2)仅在造血细胞中观察到VLA-5 mRNA的表达显着增强。人粒细胞白血病HL-60细胞向单核细胞分化,但不向粒细胞分化。 (3)细胞表面整合素VLA-5的表达仅在单核细胞分化过程中增强,且在表面表达最为突出。 (4)单核细胞分化过程中纤连蛋白诱导的细胞凋亡的敏感性显着增加,并且抗VLA-5单克隆抗体或RGD肽完全。 (5) 细胞外基质纤连蛋白显着增加外周血中正常单核细胞的凋亡,但抗纤连蛋白单克隆抗体可抑制细胞凋亡并延长正常单核细胞的存活时间 6。 ) 细胞外基质糖蛋白、生腱蛋白的表达在肿瘤组织形成过程中在空间和时间上受到限制,具体取决于基质-上皮相互作用和 de生腱蛋白的新合成是由可溶性生长因子EGF诱导的,也依赖于基质-上皮相互作用,人生腱蛋白C具有EGF样结构域,但该结构域及其衍生肽不能诱导生腱蛋白的表达。 (7)综合当前所有数据,得出结论:ECM糖蛋白纤连蛋白可能与整合素协同作用,作为单核细胞存活的负调节因子发挥重要作用。 VLA-5,在单核细胞分化过程中特征性增加。在本研究项目的后半部分,展示了以下新发现:(8)使用精心设计的表达克隆方法,我们首次获得成功分离和分子表征一个新的相关基因(cDNA 及其基因组),该基因编码关键的糖基转移酶、神经节苷脂 GM3 合酶(唾液酸转移酶-1),负责神经节苷脂 GM3 是一种普遍存在但结构最简单的膜分子,此前已被证明具有与细胞生长控制、恶性转化、细胞间识别和分化密切相关的多种生物学功能。诱导人骨髓性白血病细胞较少。

项目成果

期刊论文数量(27)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nakamura,M., Saito,M., et al.: "Rapid Internalization of Exogenous Ganglioside GM3 and its Metabolism to Ceramide in Human Myelogenous Leukemia HL-60 Cells---" FEBS Lett.400. 350-354 (1997)
Nakamura,M.、Saito,M. 等人:“外源性神经节苷脂 GM3 的快速内化及其在人骨髓性白血病 HL-60 细胞中代谢为神经酰胺---”FEBS Lett.400。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nakamura, M., Saito, M., et al.: "CMP-NeuAc : Galbeta1*4GlcNAcalpha2*6Sialyltransferase Catalyzes NeuAc Transfer to Glycolipids." J.Lipid Res.38. 1795-1806 (1997)
Nakamura, M.、Saito, M. 等人:“CMP-NeuAc:Galbeta1*4GlcNAcalpha2*6 唾液酸转移酶催化 NeuAc 转移到糖脂。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
斎藤政樹: "医科分子生物学 改定第3版(村松正美、谷口維紹編)" 南江堂, 501 (1997)
齐藤正树:《医学分子生物学修订版第 3 版(村松雅美和谷口伊翔编辑)》 Nankodo,501(1997)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nakamura, M., Saito, M., et al.: "Rapid Internalization of Exogenous Ganglioside GM3 and Its Metabolism to Ceramide in Human Myelogenous Leukemia HL-60 Cells Comparing with Control Gangliside GMl." FEBS Lett.400. 350-354 (1997)
Nakamura,M.,Saito,M.,等人:“与对照神经节苷脂 GM1 相比,外源性神经节苷脂 GM3 的快速内化及其在人骨髓性白血病 HL-60 细胞中代谢为神经酰胺”。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
斎藤 政樹: "糖鎖生物学(蛋白質核酸酵素増刊号)" 共立出版株式会社(印刷中), 250 (1998)
齐藤正树:《糖生物学(蛋白质核酸酶特刊)》共立出版(正在出版),250(1998)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SAITO Masaki其他文献

Resourceability on Nuclear Fuel Cycle by Transmutation Approach
通过嬗变方法实现核燃料循环的资源化

SAITO Masaki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SAITO Masaki', 18)}}的其他基金

Molecular mechanisms of primary ciliary resorption and cilia-dependent cell cycle regulation.
原发性纤毛吸收和纤毛依赖性细胞周期调节的分子机制。
  • 批准号:
    23770136
  • 财政年份:
    2011
  • 资助金额:
    $ 4.99万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Functions of Complex Glycosphingolipids in the Cell Proliferation, Differentiation, and Cell Death Controlled at the Gene Level of Their Synthesizing Enzymes, and Their Medical Applications
复合鞘糖脂在其合成酶基因水平控制的细胞增殖、分化和细胞死亡中的功能及其医学应用
  • 批准号:
    14370310
  • 财政年份:
    2002
  • 资助金额:
    $ 4.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Study on Ultra-Long Life Ores Lolled with Transuranium Fuels
超长寿命矿石浸延超铀燃料的研究
  • 批准号:
    11694138
  • 财政年份:
    1999
  • 资助金额:
    $ 4.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Expression Mechanism and Its Medical Application of Ganglioside GM3 Synthase Gene Which Is Relevantly Related With Growth and Differentiation of Hematopoietic Cells
与造血细胞生长分化相关的神经节苷脂GM3合酶基因的表达机制及其医学应用
  • 批准号:
    10470206
  • 财政年份:
    1998
  • 资助金额:
    $ 4.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Nuclear Energy Systems with Zero Release of Radioactive Materials
放射性物质零释放的核能系统
  • 批准号:
    09044146
  • 财政年份:
    1997
  • 资助金额:
    $ 4.99万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Exploitation on Biological Activities of Sialoglycosphingolipids and Their Synthetic Family Compounds (Neoglycollipids)
唾液酸鞘糖脂及其合成家族化合物(新糖脂)的生物活性开发
  • 批准号:
    09359001
  • 财政年份:
    1997
  • 资助金额:
    $ 4.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Regulatory Mochanisms For Proliferation, Differentiation, And Apoptosis of Leukemic Cells In Reference To Cell Cycle Phases.
白血病细胞增殖、分化和凋亡与细胞周期阶段相关的调节机制。
  • 批准号:
    06454349
  • 财政年份:
    1994
  • 资助金额:
    $ 4.99万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Basic Study on MHD Power Generation System by Using High Density Liquid-Metal Two-Phase Natural Circulation
高密度液态金属两相自然循环磁流体发电系统基础研究
  • 批准号:
    04452328
  • 财政年份:
    1992
  • 资助金额:
    $ 4.99万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Effects of cdc2 gene and EMC tenasc in on regulation of growth and differentiation of hematopoietic cells
cdc2基因和EMC tenasc对造血细胞生长和分化的调控作用
  • 批准号:
    04454575
  • 财政年份:
    1992
  • 资助金额:
    $ 4.99万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Studies on Expression-Mechanism (s) of Malignant Phenotypes Using Growth-Factor Gene-Transfer Methods
使用生长因子基因转移方法研究恶性表型的表达机制
  • 批准号:
    02454521
  • 财政年份:
    1990
  • 资助金额:
    $ 4.99万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似国自然基金

MMP3调控细胞外囊泡CD9与纤连蛋白互作在口腔鳞癌淋巴结转移中的作用机制
  • 批准号:
    82303297
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
肠道纤连蛋白组装机制和纤维化中的病理调控
  • 批准号:
    82370524
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
基于HS/纤连蛋白/整合素α5β1/pPD-L1探讨化瘀丸联合免疫检查点抑制剂干预肺癌的机制
  • 批准号:
    82374538
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
富含亮氨酸跨膜纤连蛋白FLRT2上调EPSTI1促进内皮炎症致动脉粥样硬化的机制研究
  • 批准号:
    82370462
  • 批准年份:
    2023
  • 资助金额:
    47 万元
  • 项目类别:
    面上项目
仿纤连蛋白涂层改性镁合金植入物在骨质疏松条件下实现序贯免疫调节促骨整合的研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Regulation of Flt 1 Splicing by Fibronectin and Integrin Signaling During Aging
衰老过程中纤连蛋白和整合素信号传导对 Flt 1 剪接的调节
  • 批准号:
    10777172
  • 财政年份:
    2023
  • 资助金额:
    $ 4.99万
  • 项目类别:
Engineering a Kidney Organoid Model to Investigate Fibronectin-TGF-beta Signaling in Renal Fibrosis
设计肾脏类器官模型来研究肾纤维化中的纤连蛋白-TGF-β信号传导
  • 批准号:
    2302580
  • 财政年份:
    2023
  • 资助金额:
    $ 4.99万
  • 项目类别:
    Standard Grant
Mechanisms of anti-tumor activity of group A Streptococcus in pancreatic adenocarcinoma
A族链球菌抗胰腺癌的作用机制
  • 批准号:
    10662559
  • 财政年份:
    2022
  • 资助金额:
    $ 4.99万
  • 项目类别:
A novel mechanism of fibronectin/LILRB4 immune checkpoint in the regulation of the tumor microenvironment
纤连蛋白/LILRB4免疫检查点调节肿瘤微环境的新机制
  • 批准号:
    22K15519
  • 财政年份:
    2022
  • 资助金额:
    $ 4.99万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
2023 Fibronectin, Integrins and Related Molecules Gordon Research Conference and Gordon Research Seminar
2023年纤连蛋白、整合素及相关分子戈登研究会议暨戈登研究研讨会
  • 批准号:
    10608783
  • 财政年份:
    2022
  • 资助金额:
    $ 4.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了